Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Iowa guideIowa Bids and Bidding Guide
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Iowa
  4. ›Healthcare and Medical Services
  5. ›Metabolomic Analysis

University of Iowa·Iowa

Metabolomic Analysis

Closes 12/17/2025$100k – $500kRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The University of Iowa is seeking a supplier to provide Targeted Bile Acid Assay and Untargeted Metabolomics analysis for the University of Iowa Department of Occupational and Environmental Health. The supplier must be able to determine the relative and absolute abundance of metabolites in complex biological matrices and provide the Targeted Bile Acid Assay to determine the absolute abundance of all bile acids. The university requires the supplier to provide detailed information on their ability to meet this need, the methodologies utilized to achieve accurate results, and the amount of metabolites measured during analysis. • The supplier must be able to provide sample analysis of both Targeted Bile Assay and Untargeted Metabolomics. • The supplier must be capable of determining the relative and absolute abundance of metabolites in complex biological matrices. • The supplier must provide the Targeted Bile Acid Assay to determine the absolute abundance of all bile acids. • The supplier must provide detailed information on their ability to meet this need, the methodologies utilized to achieve accurate results, and the amount of metabolites measured during analysis.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Chad Steffens(Purchasing Contact)

[email protected]

(319) 467-1448

Key dates

Opened
11/12/2025
Questions due
12/2/2025
Closes
12/17/2025
Duration
1 year

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
541710
Solicitation №
18504

Budget estimate

$100,000 – $500,000

The budget for this opportunity is likely to be in the range of $100,000 to $500,000, considering the complexity of the services required and the duration of the contract. The University of Iowa has a large budget for research and development, and the cost of metabolomics analysis can vary widely depending on the scope and complexity of the project. Factors that may influence the likely payment range include the number of samples to be analyzed, the frequency of analysis, and the level of expertise required.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 60%

NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 8/13/2024

U.S. National Institutes of Health·United States of America

60% match

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. National Institutes of Health·United States of America

60% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Closes 11/17/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

59% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: National Somatic Mosaicism Commons Data Analysis & Organizational Center (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

59% match

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 5/12/2025

U.S. National Institutes of Health·United States of America

59% match

The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)

Closes 11/22/2028Opened 6/16/2025

U.S. National Institutes of Health·United States of America

59% match

Transformative Technologies for Experimental and Computational RNome Characterization and Functional Analysis

Closes 2/14/2027Opened 8/5/2026

U.S. National Science Foundation·United States of America

59% match

Analysis

Rolling / TBD closeOpened 3/17/2020

U.S. National Institutes of Health·United States of America

58% match

Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)

Closes 6/30/2027Opened 9/14/2026

U.S. National Institutes of Health·United States of America

57% match

Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)

Closes 3/1/2027Opened 1/8/2026

U.S. National Institutes of Health·United States of America

57% match

NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

Closes 5/8/2028Opened 7/8/2025

U.S. Department Of Health And Human Services·Maryland

57% match

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases

Closes 5/31/2029Opened 9/30/2024

U.S. National Institutes of Health·United States of America

56% match

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Closes 9/7/2027Opened 11/18/2024

U.S. National Institutes of Health·United States of America

56% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. National Institutes of Health·United States of America

56% match

Genomic Community Resources (U24 Clinical Trials Not Allowed)

Closes 1/24/2027Opened 2/9/2026

U.S. National Institutes of Health·United States of America

56% match

Genomic Data Generation Center for the Gabriella Miller Kids First Pediatric Research Program (U24 Clinical Trial Not Allowed)

Closes 1/8/2027Opened 5/14/2025

U.S. National Institutes of Health·United States of America

56% match

Research on the Ethical, Legal and Social Implications (ELSI) of Genomics

Closes 2/15/2027Opened 6/3/2026

U.S. National Institutes of Health·United States of America

56% match

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Closes 12/14/2026Opened 6/6/2025

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

55% match

DoW Bone Marrow Failure, Resource Development Award

Closes 11/4/2026Opened 6/17/2026

U.S. National Institutes of Health·United States of America

55% match

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Closes 11/6/2026Opened 8/1/2023

U.S. National Institutes of Health·United States of America

55% match

Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

Closes 11/9/2026Opened 1/29/2026

U.S. National Institutes of Health·United States of America

55% match

INCLUDE Project: Omics Phenotypes Related to Down Syndrome (X01 Clinical Trial Not Allowed)

Closes 6/14/2027Opened 7/28/2026

U.S. Food and Drug Administration·United States of America

55% match

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

Rolling / TBD closeOpened 11/20/2024